Monday , December 18 2017
Home / Conditions (page 49)



“Synjardy” Approved for Type 2 Diabetes

Single-tablet approach hoped to boost treatment compliance and help patients better manage condition.. Synjardy contains empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, a biguanide. It is not for the treatment of type 1 diabetes or diabetic ketoacidosis. The drug label contains a boxed warning on the risk of …

Read More »

Potential, Prediabetes Genetic Marker Discovered

Research pinpoints molecular link between insulin resistance and mitochondrial changes… A recent study published in Clinical Epigenetics said researchers sought to discover if they could find any biomarkers in a group of patients with no pre-existent diabetes or cardiovascular disease, but indication of prediabetes and insulin resistance. Researchers analyzed data …

Read More »